Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
When the p Value Doesn't Cut It: The Fragility Index Applied to Randomized Controlled Trials in Colorectal Surgery
David W Nelms1, H David Vargas, Ryan S Bedi
1Department of Colon and Rectal Surgery at the Ochsner Clinic, New Orleans, Louisiana.
Many colorectal surgery trials have a low fragility index, indicating potential lack of robustness. Over half of trials lost more patients than needed to alter statistical significance, highlighting the need to assess trial robustness beyond p-values.
Area of Science:
- Colorectal Surgery
- Clinical Trials
- Statistical Analysis
Background:
- The American Statistical Association recommends statistical methods beyond p ≤ 0.05.
- The fragility index measures the minimum patient outcome changes needed to alter statistical significance.
- Previous reviews indicate many randomized controlled trials (RCTs) have low fragility indices, suggesting limited robustness.
Purpose of the Study:
- To review the fragility indices of RCTs in colorectal surgery.
- To assess the robustness of published colorectal surgery RCTs.
Main Methods:
- A systematic PubMed search identified colorectal surgery RCTs published between 2016 and 2018 with dichotomous primary outcomes (p ≤ 0.05).
- Fragility index and number of patients lost to follow-up were the main outcome measures.
- The percentage of trials with lost patients exceeding the fragility index was calculated.
Main Results:
- 90 colorectal surgery RCTs met the inclusion criteria.
- The median fragility index was 3 (IQR, 1-10).
- In 57% of trials (51/90), the number of patients lost to follow-up was greater than the fragility index.
Conclusions:
- Most colorectal surgery RCTs exhibit low fragility indices.
- A significant proportion of trials (57%) had more lost patients than the fragility index, potentially altering study conclusions.
- Assessing clinical trial robustness beyond p-values is crucial for reliable clinical application.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
15:49Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
Randomized Experiments
Simple randomization
Simple...
Relative Risk
The Mantel-Cox Log-Rank Test